Session Description
This session will cover the challenging topic of the management of metatstatic Pheochromocytomas and Paragangliomas (MPPGLs). Â Clinical predictors of metastases, current evidence-based pharmacotherapeutic agents used to treat individuals living with MPPGLs, and emerging therapies for patients with MPPGLs will be discussed.